Bioaerosol Sampling Device (BSD) Clinical Study

Description

The goal of this clinical trial is to learn about the bioaerosol sampling device (BSD) and how it can sample patient bioaerosols (breath) and patient's nares for the detection of COVID-19 viral particles in patients seeking to be tested for COVID-19.

Conditions

COVID-19

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to learn about the bioaerosol sampling device (BSD) and how it can sample patient bioaerosols (breath) and patient's nares for the detection of COVID-19 viral particles in patients seeking to be tested for COVID-19.

BIOAEROSOL SAMPLING DEVICE (BSD) CLINICAL STUDY: Performance of Respiratory Pathogen Bioaerosol Sampling Device Compared to Matched Swab Sample With Molecular and Antigen Assays That Can Detect SARS-CoV-2 Phase II Validation

Bioaerosol Sampling Device (BSD) Clinical Study

Condition
COVID-19
Intervention / Treatment

-

Contacts and Locations

S. Gate

JPRA Enterprise, LLC, S. Gate, California, United States, 90280

Hollywood

Alfa Medical Research, Hollywood, Florida, United States, 33204

Pembroke Pines

Alfa Medical Urgent Care, Pembroke Pines, Florida, United States, 33029

Houston

HDH Research, Houston, Texas, United States, 77009

Houston

HDH Research, Houston, Texas, United States, 77022

Humble

HDH Research, Humble, Texas, United States, 77338

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    5 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Cantor BioConnect, Inc.,

    Robert Azurin, MD, PRINCIPAL_INVESTIGATOR, JPRA Enterprises, LLC

    Study Record Dates

    2024-05-19